Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Total Current Liabilities (2017 - 2025)

Historic Total Current Liabilities for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to $17.3 million.

  • Regenerative Medical Technology's Total Current Liabilities fell 3717.63% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year decrease of 3717.63%. This contributed to the annual value of $29.0 million for FY2024, which is 3019.11% up from last year.
  • Latest data reveals that Regenerative Medical Technology reported Total Current Liabilities of $17.3 million as of Q3 2025, which was down 3717.63% from $30.5 million recorded in Q2 2025.
  • Regenerative Medical Technology's Total Current Liabilities' 5-year high stood at $30.5 million during Q2 2025, with a 5-year trough of $1.1 million in Q2 2021.
  • For the 5-year period, Regenerative Medical Technology's Total Current Liabilities averaged around $16.0 million, with its median value being $13.7 million (2023).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first crashed by 8976.8% in 2021, then surged by 36300.27% in 2022.
  • Regenerative Medical Technology's Total Current Liabilities (Quarter) stood at $4.2 million in 2021, then soared by 184.48% to $12.0 million in 2022, then soared by 85.42% to $22.2 million in 2023, then skyrocketed by 30.19% to $29.0 million in 2024, then tumbled by 40.37% to $17.3 million in 2025.
  • Its last three reported values are $17.3 million in Q3 2025, $30.5 million for Q2 2025, and $29.9 million during Q1 2025.